Cochlear Ltd

Common Name
Cochlear
Country
Australia
Sector
Healthcare
Industry
Medical Devices
Employees
5,500
Ticker
COH
Exchange
ASX
Description
Cochlear Ltd is a global leader in the medical technology sector, specializing in the development and manufacturing of implantable hearing solutions. The company’s primary products include cochlear im...

Cochlear's Financial Statements Preview

Below are the financial statements of Cochlear, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of AUD
2025
2024
Revenue
2,343.1b
2,235.6b
Cost of sales
-615.2b
-562.1b
Gross profit
1,727.9b
1,673.5b
Selling, marketing and general expenses
-732b
-685b
Research and development expenses
-291.5b
-277b
Administration expenses
-207.9b
-212.6b
Other income
26.4b
11b
Other expenses
-4.2b
-34.3b
Share of losses on equity-accounted investments
-0.9b
-0.6b
Results from operating activities
517.8b
475b
Finance income - interest
11.7b
19b
Finance expense - interest
-11b
-9.2b
Net finance income
0.7b
9.8b
Profit before income tax
518.5b
484.8b
Income tax expense
-129.6b
-128b
Net profit
388.9b
356.8b
Download Data

Verified Sources Behind Cochlear’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cochlear’s data sources below and access millions more through our Disclosure Search.

a. Cochlear's Annual Report 2024
a. Cochlear's Annual Report 2024
b. Cochlear's Annual Report 2025
b. Cochlear's Annual Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?